Fri, May 11, 2012
Thu, May 10, 2012
Wed, May 9, 2012
Tue, May 8, 2012
Mon, May 7, 2012
Sat, May 5, 2012
Fri, May 4, 2012
Thu, May 3, 2012
[ Thu, May 03rd 2012 ] - Market Wire
00 p.m. EDT
Wed, May 2, 2012
Tue, May 1, 2012
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ] - Market Wire
Hologic to Acquire Gen-Probe
Sun, April 29, 2012
Sat, April 28, 2012
Fri, April 27, 2012
Thu, April 26, 2012

Syneron to Present at the 11th Annual JMP Securities Research Conference


//health-fitness.news-articles.net/content/2012/ .. h-annual-jmp-securities-research-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


May 03, 2012 16:15 ET

Syneron to Present at the 11th Annual JMP Securities Research Conference

YOKNEAM, ISRAEL--(Marketwire - May 3, 2012) - Syneron Medical Ltd. (NASDAQ: [ ELOS ]), the leading global aesthetic device company, announced today that Louis P. Scafuri, Chief Executive Officer, is scheduled to present at the 11th Annual JMP Securities Research Conference in San Francisco, CA.

Conference: 11th Annual JMP Securities Research Conference
Date: Wednesday, May 16, 2012
Time: 9:00 a.m. PT / 12:00 p.m. ET

The presentation will be webcast live over the Internet and can be accessed through the Investor Relations section on Syneron's website at [ www.syneron.com ]. Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentation.

About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: [ ELOS ]) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets, services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.



Publication Contributing Sources